Trial Details
COMPLETEDBasic Information
| Clinical ID | c3411 |
|---|---|
| Identifier | NCT02096861 |
| Trial Title | Demonstrate Noninferiority in Efficacy and to Assess Safety of CT-P13 in Patients With Active Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | BIOLOGICAL: CT-P13|BIOLOGICAL: Remicade |
Participant Information
| Sponsor | Celltrion |
|---|---|
| City | Nashville |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2014-09-19 |
|---|---|
| Primary Completion Date | 2016-01-11 |
| Completion Date | 2017-02-15 |